Loading…
Daré Bioscience, Inc. is projected to decline to $2.21 by 2027, a -5% move from its current price of $2.33. DARE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.21 | $2.33 | $2.45 | -0.02% |
| May 30 | $2.17 | $2.33 | $2.50 | -0.04% |
| May 31 | $2.13 | $2.33 | $2.55 | -0.06% |
| Jun 1 | $2.10 | $2.33 | $2.58 | -0.08% |
| Jun 2 | $2.07 | $2.33 | $2.61 | -0.10% |
| Jun 3 | $2.05 | $2.33 | $2.64 | -0.11% |
| Jun 4 | $2.03 | $2.33 | $2.67 | -0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.03 | $2.33 | $2.67 | -0.13% |
| Week 2 | $1.92 | $2.32 | $2.82 | -0.27% |
| Week 3 | $1.83 | $2.32 | $2.94 | -0.40% |
| Week 4 | $1.76 | $2.32 | $3.04 | -0.53% |
| Week 5 | $1.71 | $2.31 | $3.14 | -0.67% |
| Week 6 | $1.66 | $2.31 | $3.23 | -0.80% |
| Week 7 | $1.61 | $2.31 | $3.31 | -0.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Daré Bioscience, Inc. is a healthcare company focused on developing therapies across contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. Founded in 2015 and headquartered in San Diego, California, the company’s portfolio includes XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis, and Ovaprene, a hormone-free monthly intravaginal contraceptive.
Its pipeline also includes Sildenafil Cream for topical treatment of female sexual arousal disorder, and DARE-HRT1, DARE-VVA1, DARE-HPV, DARE-PDM1, DARE-LARC1 and other assets in women’s health.
Daré Bioscience, Inc. trades as a Healthcare stock with current price $2.37 and a market capitalization of $35.5M, ranking 4740 by market cap. The price outlook shows a potential upward path across several years, with 2026 avg $2.37, 2029 avg $2.92, 2040 avg $5.49, and 2050 avg $13.33, indicating meaningful long-run upside.
The stock also exhibits a wide 30-day price range and notable volatility, underscored by a 30-day range of $1.64 to $3.43 and annualized volatility of 100%.
A major floor 57.8% below — a decisive break under it would weaken the trend.
The nearest floor, 23.2% below — buyers have tended to step in here.
The nearest ceiling, 40.3% above — a clean break opens room to run.
A major ceiling 69.2% above — clearing it would confirm fresh momentum.
Key DARE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DARE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.36 | Sell | $2.35 | Sell |
| MA 10 | $2.40 | Sell | $2.40 | Sell |
| MA 20 | $2.55 | Sell | $2.42 | Sell |
| MA 50 | $2.15 | Buy | $2.25 | Buy |
| MA 100 | $1.95 | Buy | $2.11 | Buy |
| MA 200 | $1.99 | Buy | $2.17 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.47 | Neutral |
| Stoch RSI (14) | 24.17 | Neutral |
| CCI (20) | -48.20 | Neutral |
| Williams %R (14) | -72.50 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | -15.27 | Sell |
| Bollinger %B (20,2) | 0.34 | Neutral |
| Stochastic %K (14) | 27.50 | Neutral |
| TRIX (15) | 0.60 | Buy |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 54.18 | Neutral |
| Momentum (10) | -0.30 | Sell |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 2.37 | Sell |
| ADX (14) | 14.74 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture is NEUTRAL, with RSI(14) at 50. The price is above both its SMA50 of $2.11 and its SMA200 of $1.99, suggesting a mild near-term tilt higher. Key support is at $1.75 and resistance at $3.27, framing a 30-day trading range of $1.64 to $3.43.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.30 | $2.33 | $3.36 | 0% | Neutral | |
| $1.60 | $2.21 | $3.30 | -5% | Neutral | |
| $1.37 | $2.00 | $3.17 | -14% | Neutral | |
| $1.88 | $2.88 | $4.78 | +24% | Bullish | |
| $2.12 | $3.39 | $5.84 | +46% | Bullish | |
| $2.15 | $3.59 | $6.39 | +54% | Bullish | |
| $2.29 | $3.98 | $7.29 | +71% | Bullish | |
| $2.02 | $3.65 | $6.88 | +57% | Bullish | |
| $1.91 | $3.58 | $6.91 | +54% | Bullish | |
| $1.87 | $3.63 | $7.16 | +56% | Bullish | |
| $2.47 | $5.50 | $11.89 | +136% | Bullish | |
| $5.95 | $13.23 | $30.42 | +468% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.30 | $2.33 | $2.78 | +0.00% |
| June 2026 | $1.96 | $2.35 | $2.91 | +0.86% |
| July 2026 | $1.88 | $2.29 | $2.91 | -2.57% |
| August 2026 | $1.96 | $2.42 | $3.13 | +5.67% |
| September 2026 | $2.05 | $2.56 | $3.36 | +5.73% |
| October 2026 | $1.97 | $2.48 | $3.30 | -3.07% |
| November 2026 | $1.89 | $2.40 | $3.24 | -3.01% |
| December 2026 | $1.93 | $2.47 | $3.36 | +2.52% |
Click any year to see its month-by-month DARE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Daré Bioscience, Inc.'s 2026 outlook centres on $2.33, within a $1.30 to $3.36 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, DARE could reach as high as $3.30, with a base case around $2.21 and support toward $1.60 — roughly -5% from $2.33. Price action looks broadly range-bound.
Expect DARE to range from $1.37 to $3.17 through 2028. The $2.00 average target implies a -14% move from current prices. That is -9% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The DARE price prediction for 2029 points to an average of $2.88 (low $1.88, high $4.78) — a potential gain of +24% on today's $2.33. Momentum favours further upside here.
In 2030, DARE is projected to trade between $2.12 and $5.84, averaging $3.39 — a potential gain of +46% from today's $2.33. That is up +18% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Daré Bioscience, Inc.'s 2031 outlook centres on $3.59, within a $2.15 to $6.39 range. That is up +6% on the projected 2030 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2032, DARE could reach as high as $7.29, with a base case around $3.98 and support toward $2.29 — roughly +71% from $2.33. Buyers look set to stay in control over this stretch.
Expect DARE to range from $2.02 to $6.88 through 2033. The $3.65 average target implies a +57% move from current prices. That is -8% versus the projected 2032 average. Momentum favours further upside here.
The DARE price prediction for 2034 points to an average of $3.58 (low $1.91, high $6.91) — a potential gain of +54% on today's $2.33. Buyers look set to stay in control over this stretch.
In 2035, DARE is projected to trade between $1.87 and $7.16, averaging $3.63 — a potential gain of +56% from today's $2.33. That is up +1% on the projected 2034 average. Momentum favours further upside here.
Daré Bioscience, Inc.'s 2040 outlook centres on $5.50, within a $2.47 to $11.89 range. That is up +52% on the projected 2035 average. That marks a +136% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, DARE could reach as high as $30.42, with a base case around $13.23 and support toward $5.95 — roughly +468% from $2.33. Momentum favours further upside here.
Investing $1,000 in DARE today (≈ 429.184549 DARE) could be worth
$5,676.15
+$4,676.15 (+468%) by 2050 · US Dollar
Based on the average projected DARE price of $13.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DAREwould be worth at today's price.
$1,000 invested in DARE on May 27, 2025 (≈ 357.142863 DARE) would be worth
$832.14
-$167.86 (-16.8%) today · 0.83× · US Dollar
Based on a DARE entry price of $2.8 vs. today's $2.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.33 | $1,000 | +0.0% |
| 1 month ago | $2.24 | $1,040.18 | +4.0% |
| 3 months ago | $1.67 | $1,395.21 | +39.5% |
| 6 months ago | $1.84 | $1,266.3 | +26.6% |
| 1 year ago | $2.8 | $832.14 | -16.8% |
| All time (5.0y) ago | $15.48 | $150.52 | -84.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DARE forecast.
Our base-case forecast reaches $4.70 around 2040.
Implied market cap at $4.70: $70.4M
In the multi-year forecast, the 2026 average price is $2.37 with a 0% ROI and NEUTRAL sentiment. The 2027 forecast shows $2.18 average with -8% ROI, while 2028 shows $1.96 average with -17.1% ROI, indicating near-term softness. The 2029 forecast turns bullish with a $2.92 average and 23.3% ROI, followed by a stronger rise to $3.39 average and 43.2% ROI in 2030 (bullish).
The path continues to 2040 with an average of $5.49 and a 131.7% ROI, and to 2050 with an average of $13.33 and a 462.3% ROI, both bullish. These figures reflect a high-variance trajectory, with substantial long-run upside but notable near-term volatility; the measured risk is highlighted by an annualized volatility of 100%.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $3.39 with a 43.2% ROI and a bullish sentiment. The min/max for 2030 are $2.09 and $5.92 respectively, offering a wide projected range.
Forecasts show mixed signals across years, with 2026 averaging $2.37 (0% ROI) and neutral sentiment, then turning bullish later (2030–2050) with higher ROIs. The 2027 and 2028 periods show negative ROIs (-8% and -17.1%), reflecting volatility, while long-run horizons project substantial upside.
Yes. The 2050 forecast max is $30.65, indicating the possibility of exceeding $10 over the long term, though there is near-term variability.
Current price is $2.37 and market capitalization is $35.5M.
The 2040 forecast shows an average price of $5.49 with a 131.7% ROI and a bullish sentiment; the min is $2.47 and the max is $12.08.
Daré Bioscience, Inc. Community Discussion
0Share your Daré Bioscience, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.